Sub: Disclosure as per Regulation 30 of SEBI(LODR) Regulations,2015. With reference to the above and as per the provisions of Schedule III of SEBI(LODR) Regulations, 2015, we would like to disclose to the exchange that the Company has decided to issue notice as per the provisions of Section 25 FFA read with Section 25 F of the Industrial Disputes Act, 1947, pertaining to its parenterals and IV fluids manufacturing facility at Pune. This decision was taken as part of the restructuring exercise undertaken by the Company to streamline its operations and to exit from its noncore businesses, whose operational costs are significant but generate very nominal revenues. Please take this intimation on record
|